慢性移植物抗宿主病重点.pptVIP

(A) Overall survival from cGVHD diagnosis for patients with 1–3 versus ≥ 4 organs involved (B) for patients with classic cGVHD versus overlap syndrome and (C) for patients with delayed aGVHD versus classic cGVHD. Cumulative incidence of OS according to NIH global severity at enrollment. Graph shows 2-year survival estimates, 95% confidence intervals (in parentheses), and hazard ratios (HR). Data are from the prospective study of the US cGVHD consortium (N = 298). Reprinted with permission from Arai et al.19 * * pathogenic donor T cells that expand in response to alloantigens or autoantigens un